Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multicenter randomized double-blind placebo-controlled phase II trial of inhaled H057 for acute exacerbation of bronchiectasis
CTR20251484Phase 2Active
- Sponsor
- Shanghai Huilun Pharmaceutical Co., Ltd.
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of H-057 in bronchiectasis, sponsored by Shanghai Huilun Pharmaceutical Co., Ltd.. Started Apr 2025; status: active.
02
Drugs
H-057
03
Conditions
bronchiectasis
Beyond the preview
Go deeper on CTR20251484.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20251484.